Previous 10 | Next 10 |
Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (S...
Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Sept. 30, 2019 SEATTLE and VANCOUVER, British Columbia , Sept. 30, 2019 /CNW/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinic...
Noteworthy events during the week of September 15 - 21 for healthcare investors. More news on: CRISPR Therapeutics AG, Pluristem Therapeutics Inc., GlaxoSmithKline plc, Healthcare stocks news, , Read more ...
SEATTLE and VANCOUVER, British Columbia , Sept. 13, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that t...
SEATTLE and VANCOUVER, British Columbia , Sept. 5, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the Company ...
Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Sept. 4, 2019 SEATTLE and VANCOUVER, British Columbia , Sept. 4, 2019 /CNW/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clin...
Achieve Life Sciences, Inc. (ACHV) Q2 2019 Earnings Conference Call August 08, 2019, 16:30 ET Company Participants Jaime Xinos - EVP, Commercial Rick Stewart - Chairman and CEO John Bencich - Chief Financial and Operating Officer Cindy Jacobs - EVP and Chief Medical Officer ...
Achieve Life Sciences (NASDAQ: ACHV ): Q2 GAAP EPS of -$0.50 beats by $0.06 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SEATTLE and VANCOUVER, British Columbia , Aug. 8, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today provided an update on t...
Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 Canada NewsWire SEATTLE and VANCOUVER, British Columbia, July 30, 2019 SEATTLE and VANCOUVER, British Columbia , July 30, 2019 /CNW/ -- Ac...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced that the c...